semaglutide hrv Ozempic vs. Zepbound: How semaglutide and tirzepatide compare GLP-1 receptor agonists such as

Under-consumption of food, and even water, is a major concern, and GLP-1 RA users often experience substantial loss of lean body mass, sagging skin due to rapid weight loss, nutrient deficiencies, and chronic dehydration

doi: 10.1016/j.bioorg.2020.103743

Yes, when you stop tirzepatide, you may regain weight

Remember to report any suspected side effects from Mounjaro via the MHRA Yellow Card Scheme (website or app), which helps monitor medication safety

MEDVi has been getting attention lately (and for good reasons)

Impact on body weight: GLP-1 receptor activation tends to promote weight loss, while GIP receptor activation may promote weight gain through its effects on fat storage